| Literature DB >> 35741899 |
Chaoting Wen1, Jixian Zhang1, Haihui Zhang2, Yuqing Duan2.
Abstract
The health effects of bioactive substances in the human body are affected by several factors, including food processing conditions, storage conditions, light and heat, among others. These factors greatly limit the stability and bioavailability of bioactive substances. These problems can be solved by a novel protein-based nanocarrier technology, which has the excellent potential to enhance solubility, bioavailability, and the controlled release of bioactive substances. In addition, plant protein has the advantages of economy, environmental protection, and high nutrition compared to animal protein. In this review, the preparation, characterization, and application of plant protein-based nanocarriers are summarized. The research deficiency and future prospects of plant protein nanocarriers are emphasized.Entities:
Keywords: bioactive substances; bioavailability; nanocarriers; plant protein; preparation method
Year: 2022 PMID: 35741899 PMCID: PMC9223235 DOI: 10.3390/foods11121701
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Comparison of characteristics between animal and plant protein-based nanocarriers.
| Source | Nutrition | Environment Protection | Cost | Targeting | Biocompatibility | Drug Release Capacity |
|---|---|---|---|---|---|---|
| Animal protein | High | Non-renewable | High | Medium | High | Discontinuity |
| Plant protein | Medium | Renewable | Low | High | High | Good |
Figure 1Schematic diagram of different types of protein-based nano-carriers.
Figure 2Schematic diagram of advantages and disadvantages of different methods for preparing protein-based nanocarriers.
Figure 3Schematic diagram of factors affecting the stability of bioactive substances.
Summary of plant protein-based nanocarriers used to deliver active substances.
| Bioactive Substance | Wall Material | Nanoencapsulation Technique | Nanoencapsulation Type | Size (nm) | Purpose | References | |
|---|---|---|---|---|---|---|---|
| Polyphenol | Resveratrol | SPI | Rotary evaporation | Nanocomplex | 100 | Increase solubility and drug release | [ |
| Quercetin | Zein | Electrospun | Nanofibrous | 750 ± 310 | Increase solubility and stability | [ | |
| Quercetin | Zein | co-precipitate | Colloidal nano complex | 130–161 | Increase stability and antioxidant properties | [ | |
| Astaxanthin | Potato protein | Freeze-drying | Nanoparticles | Not studied | Improve solubility and bioavailability | [ | |
| EGCG | Zein | Antisolvent precipitation | Colloidal particles | 170–250 | Improve EE and bioactivities | [ | |
| Tangeretin | Zein | Liquid–liquid dispersion | Nanoparticles | 249 ± 4 | Increase stability | [ | |
| Cranberry procyanidins | Zein | Liquid–liquid dispersion | Nanoparticles | 392–447 | Increase LE | [ | |
| Curcumin | SPI | Freeze-drying | Nanocomplex | Not found | Increase solubility, storage stability, bioaccessibility and digestibility | [ | |
| Curcumin | Zein | Antisolvent precipitation | Nanoparticles | 92.44 ± 2.24 | Improve EE and stability | [ | |
| Curcumin | Rice bran albumin | Magnetic | Nanoparticles | 120 | Improve bioactivity and | [ | |
| Curcumin | Proso millet protein | Rotary evaporation | Nanoparticles | 250–350 | Increase solubility and heat stability | [ | |
| Curcumin | Freeze-drying | Nanocomplex | 130–220 | Increase solubility, stability, functional properties and bioaccessibility | [ | ||
| Curcumin | SPI | High pressure homogenization | Nanocomplex | Not studied | Increase solubility, stability and antioxidant properties | [ | |
| Curcumin | Soy protein | Desolvation and rotary | Nanoparticles | 220.1–286.7 | Improve stability, EE and LE | [ | |
| Resveratrol | Pea protein | Ca2+ ions induced cross-linking/cold gelation protocol | Nanoparticles | 207.6 | Improve EE and LE | [ | |
| Vitamins | Vitamin D3 | Corn protein hydrolysate | Freeze-drying | Nanocomplex | 102–121 | Increase stability and bioaccessibility | [ |
| Vitamin D3 | Soy protein | Ionic gelation | Nanoparticles | 162–243 | Improve EE and LE | [ | |
| Vitamin D | Pea protein | High pressure homogenization | Nanoemulsions | 170–350 | Improve EE and bioavailability | [ | |
| Riboflavin | Soy protein | Salt-induced gelation | Nano-hydrogels | Not studied | Increase bioaccessibility | [ | |
| Riboflavin | Soy protein | Ultrasound pre-treatment and transglutaminase-induced gels | Nano-hydrogels | Not studied | Increase gel strength, EE and gel yield; Decrease the digestibility | [ | |
| Folic acid | Soy protein | High pressure homogenization and heat | Nanogels | Not studied | Increase EE and stability | [ | |
| Vitamin D3 | Zein | Phase | Nanoparticles | 86–200 | Increase EE and stability | [ | |
| Vitamin E | Gliadin | Desolvation | Nanoparticles | 450–475 | Increase EE | [ | |
| Others | RA | Gliadin | Desolvation | Nanoparticles | 500 | Increase EE and controlled release | [ |
| Cyclophosphamide | Gliadin | Electrospray deposition | Nanoparticles | Not studied | Increase controlled release | [ | |
| β- carotene | Barley protein | Spray-dried and enzymatic degradation | Nano-encapsulations | 20–30 | Increase controlled release | [ | |
| β- carotene | Barley protein | High pressure homogenization | Nanoparticles | 90–150 | Increase storage stability and bioaccessibility | [ | |
| Essential oils | Zein | High-speed mix | Nanospherical particles | Not found | Increase bioaccessibility | [ | |
| Essential oils | Zein | Liquid–liquid dispersion | Nanoparticles | Not found | Increase solubility, antimicrobial and antioxidant properties | [ | |
| Lutein | Zein | SEDS | Nanoparticles | Not found | Increase EE and controlled release | [ |
Note: EGCG represents epigallocatechin gallate; EE represents encapsulation efficiency; SPI represents soy protein isolate; LE represents loading efficiency; RA represents all-trans-retinoic acid; SEDS represents solution enhanced dispersion by supercritical fluids.